Clinical features and correlation research of fever in systemic lupus erythematosus patients
Feng-hong YUAN,Ling-yun SUN,Wen-you PAN,Xiang-dang WANG,Jie-ping PAN,NG ZHA,Kui-lin TAN,Jing LI,Zhi-wei CHEN,Xiang DING,Xian QIAN,Zhan-yun DA,Juan TAO,Mei-mei WANG,Yao-hong ZOU
DOI: https://doi.org/10.3760/cma.j.issn.1007-7480.2011.10.003
2011-01-01
Abstract:Objective To investigate the clinical features of systemic lupus erythematosus (SLE) patients with fever and find out the related factors.Methods Data was collected by the same methods in the past ten years in fifteen hospitals in Jiangsu province and then the data were retrospectively analyzed.The potentially possible risk factors of fever in SLE were selected and then analyzed by chi-square test,Wilcoxon rank sum test and Logistic regression analysis.Results All 1762 patients were investigated.Seven hundred and twenty-nine had active fever.Age at hospitalization,initially treated patients,photosensitivity,serositis,nervous system involvement,generalized lymphadenopathy/hepatosplenomegaly,white blood cell count (WBC),haemoglobin (HB),erythrocyte sedimentation rate (ESR),C-reaction protein (CRP),alanine aminotransferase (ALT),albumin (ALB),serum creatinine (Scr),complement C3,anti-dsDNA antibodies positive rate,anti-Sm antibodies positive rate,SLEDAI score and past therapies were factors associated with SLE fever.Logistic regression analysis showed that abnormal WBC count (OR=1.396,95%CI 1.114-1.711,P=0.004),CRP(OR=1.005,95%CI 1.002-1.009,P=0.002),ALT(OR=1.003,95%CI 1.001-1.005,P=0.005),Scr (OR=0.997,95%CI0.995-0.999,P=0.007),HB (OR=0.986,95%CI 0.981-0.992,P=0.000),age (OR =0.984,95% CI 0.974-0.993,P=0.001 ) and past usage of cyclophosphamide (CTX) (OR =0.557,95%CI 0.382-0.813,P=0.002) were correlated with SLE fever.Conclusion Fever is one of the most common clinical manifestations of SLE patients.Leucopenia,elevated CRP levels,liver function abnormalities,anemia,younger age are risk factors for SLE fever,while renal impairment and past usage of CTX are protective factors.